University of Western Australia
Also known as: Department of Gastroenterology, Fremantle Hospital | Faculty of Health and Medical Sciences University of Western Australia | Fremantle Hospital | Fremantle Hospital and Health Service | Fremantle Hospital, WA, Australia | Head of Department, Medical Oncology, Sir Charles Gairdner Hospital | Lions Eye Institute, The University of Western Australia | Perth Medical School | Princess Margaret Hospital for Children | Princess Margaret Hospital for Children (Australia) | Princess Margaret Hospital for Children, Australia | Royal Perth Hospital | Royal Perth Hospital / University of Western Australia | School of Medicine and Pharmacology, Royal Perth Hospital | School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital | School of Paediatrics and Child Health, University of Western Australia | School pf Medicine and Pharmacology, Royal Perth Hospital. | Sir Charles Gairdner Hospital | Sir Charles Gairdner Hospital - Nedlands | Telethon Kids Institute, University of Western Australia, Perth, Australia | The University of Western Australia | University Department of Medicine, Royal Perth Hospital, University of Western Australia | University of Western Australia and Royal Perth Hospital | University of Western Australia, Fremantle Hospital | William Pomat | Zohaib Akram
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1988Last known activity
Jan 31, 2026
Timeline
1910s
- Jan 1, 1911
University of Western Australia— Founded
Drugs by trial phase (117 distinct, 74 trials)
Phase 4 (46 own, 0 via acquisition)
Phase 3 (36 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Autonomic Nervous System Diseases
- Bacteremia
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Central Nervous System Neoplasms
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Conjunctivitis
- Conjunctivitis, Allergic
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Delirium
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Dyslipidemias
- Edema
- Gastroenteritis
- Gastroesophageal Reflux
- Gastrointestinal Stromal Tumors
- Graft vs Host Disease
- Hypertension
- Hypertriglyceridemia
- Hypotension
- Hypothyroidism
- Infections
- Inflammation
- Influenza, Human
- Insulin Resistance
- Ischemia
- Keloid
- Kidney Diseases
- Kidney Failure, Chronic
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Lipid Metabolism Disorders
- Liver Neoplasms
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Macular Edema
- Malaria
- Malaria, Falciparum
- Melanoma
- Meningitis
- Mesothelioma
- Metabolic Syndrome
- Mucositis
- Muscle Cramp
- Mycobacterium Infections
- Mycobacterium Infections, Nontuberculous
- Neoplasm Metastasis
- Neoplasms
- Nervous System Diseases
- Nervous System Neoplasms
- Neuroblastoma
- Neurotoxicity Syndromes
- Obesity
- Otitis Media
- Ovarian Neoplasms
- Peritonitis
- Pneumonia
- Polycystic Ovary Syndrome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Proctitis
- Recurrence
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Sarcoma
- Severe Acute Respiratory Syndrome
- Sexually Transmitted Diseases
- Spasm
- Syndrome
- Ulcer
- Ureteral Neoplasms
- Urethral Neoplasms
- Urinary Bladder Neoplasms
- Urticaria
Recent trials (50)
- NCT07309614CollaboratorPhase 3Jan 31, 2026
- NCT07052162CollaboratorPhase 4Jul 31, 2025
- NCT06817421CollaboratorPhase 4Apr 30, 2025
- NCT06461429CollaboratorN/AFeb 1, 2025
- NCT05509153CollaboratorPhase 2Nov 1, 2022
- NCT05182931CollaboratorPhase 2Jul 14, 2022
- NCT05072314CollaboratorPhase 4Feb 28, 2022
- NCT05072314Overall official - principal investigatorPhase 4Feb 28, 2022
- NCT05087381CollaboratorPhase 4Oct 1, 2021
- NCT04899765CollaboratorPhase 4May 20, 2021
- NCT06462001OfficialPhase 3Dec 10, 2020
- NCT04552379Study chairPhase 3Dec 1, 2020
- NCT04552379Overall official - principal investigatorPhase 3Dec 1, 2020
- NCT04478500Overall official - principal investigatorPhase 3Oct 15, 2020
- NCT04478500Reponsible party - principal investigatorPhase 3Oct 15, 2020
Details
- Founded
- Perth, AU Jan 1, 1911
- Last known activity
- Jan 31, 2026